retatrutide peptide health benefits Retatrutide: The Redefining Metabolic Health, Inflammation, a… Retatrutide vs Tirzepatide (2026): Differences
Description
Research funding: Canadian Institutes of Health Research (CIHR) (FDN-148396)
GLP-1 receptor agonists are potent insulin sensitisers, explains Sonia Gibson, MD, a board-certified physician in endocrinology, diabetes, and metabolism, and the endocrinology physician lead at Allara Health
58 Phase 2a trial of GSBR-1290 (120mg) in 40 healthy obese volunteers over 8 weeks demonstrated a significant reduction in BW (120 mg: -4.74%
Quick, private, and no commitment to continue
SURMOUNT-1 was the landmark study
Ready to take control of your skin again
